triiodothyronine has been researched along with (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moriwaki, H; Muto, Y; Nakamura, N; Shidoji, Y | 1 |
1 other study(ies) available for triiodothyronine and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
Article | Year |
---|---|
Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Humans; Insulin-Like Growth Factor II; Kinetics; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor alpha; Tretinoin; Triiodothyronine; Tumor Cells, Cultured | 1996 |